People: Affymetrix, Inc. (AFFX.O)

AFFX.O on Nasdaq

7.22USD
9 Feb 2010
Price Change (% chg)

$-0.13 (-1.77%)
Prev Close
$7.22
Open
--
Day's High
$7.55
Day's Low
$7.17
Volume
1,163,995
Avg. Vol
3,046,624
52-wk High
$10.06
52-wk Low
$1.78

view people for:

Summary

Name Age Since Current Position
Fodor, Stephen 55 2009 Executive Chairman of the Board
King, Kevin 52 2009 President, Chief Executive Officer, Director
Batty, John 54 2007 Chief Financial Officer, Executive Vice President
Runkel, John 53 2008 Executive Vice President, General Counsel, Secretary
Diekman, John 66 1999 Director
Berg, Paul 82 1993 Director
Young, John 77 1993 Director
Trice, Robert 62 2006 Director
Wayman, Robert 64 2007 Director
Guthart, Gary 43 2009 Director
» Insider Trading

Biographies

Name Description
Fodor, Stephen Dr. Stephen P.A. Fodor has been Founder and Executive Chairman of Affymetrix Inc. Dr. Fodor has served as Director since 1993, Executive Chairman since 2009, Chief Executive Officer from 1997 to 2008 and Chairman from 1999 to 2008. At various times between 1993 and 1997, Dr. Fodor served as President, Chief Operating Officer and Chief Technology Officer. Dr. Fodor was Vice President and Director of Physical Sciences at the Affymax Research Institute from 1989 to 1993. Dr. Fodor is also a founder and the Chairman of the Board of Perlegen Sciences, Inc. (“Perlegen”), a genomics company formed in September 2000 by the Company and currently partly owned by the Company. Dr. Fodor also serves as a director of Sunesis Pharmaceuticals, Inc. and a Trustee of the Carnegie Institution of Washington.
King, Kevin Mr. Kevin M. King has been appointed as Chief Executive Officer and Director of Affymetrix Inc., effective January 1, 2009 and has been the President of the company since September 2007. Mr. King joined the Company in January 2007 as President of Life Sciences Business and Executive Vice President and served in that capacity until September 2007. From February 2005 until June 2006, Mr. King was President and Chief Executive Officer of Thomson Healthcare. From 1997 to 2004, Mr. King held various managerial positions at General Electric Healthcare, most recently as Vice President and General Manager of Global Clinical Systems from June 2000 to November 2004.
Batty, John John C. Batty joined Affymetrix, Inc. in June 2007 as Executive Vice President and Chief Financial Officer. Mr. Batty served as Senior Vice President of Finance and Chief Financial Officer of Credence Systems Corporation from 2005 to 2007. From 1999 to 2005, Mr. Batty held several management positions with Network Equipment Technologies Inc., a global provider of networking technology platforms, most recently as its Chief Operating Officer from 2001 to 2004.
Runkel, John John F. Runkel, Jr. joined Affymetrix, Inc. in October 2008 as Executive Vice President, General Counsel and Secretary. Mr. Runkel served as Senior Vice President, General Counsel and Secretary of Intuitive Surgical, Inc., a provider of minimally-invasive robotic surgery technology, from 2006 to 2007. From 2004 to 2005, Mr. Runkel served as Senior Vice President of VISX Incorporated, a provider of laser vision correction technology, and as Vice President, General Counsel and Secretary from 2001 to 2004. Mr. Runkel received his law and undergraduate degrees from the University of California, Los Angeles.
Diekman, John John D. Diekman has served as a Director of Affymetrix, Inc. since 1993. Dr. Diekman has served as a managing partner of 5AM Ventures, a life sciences investment partnership, since August 2002. From June 1998 until July 2002, Dr. Diekman served as a managing director of Bay City Capital, a life sciences merchant bank. Dr. Diekman served as Chairman of the Company from 1993 to August 1999 and served as Vice Chairman from July 1999 to December 1999. Dr. Diekman served as Chief Executive Officer of the Company from July 1995 to March 1997. Prior to such time, Dr. Diekman served as President and Chief Operating Officer of Affymax N.V. from 1991 to March 1995 and as Chairman of the Board of Affymax from 1994 to July 1995.
Berg, Paul Paul Berg has served as a Director of Affymetrix, Inc. since 1993. Dr. Berg is Cahill Professor of Cancer Research and Biochemistry, Emeritus and Director, Emeritus of the Beckman Center for Molecular and Genetic Medicine at the Stanford University School of Medicine. He received the Nobel Prize in Chemistry in 1980, the National Medal of Science in 1983, and is a member of the National Academy of Sciences, the Royal Society, London, and the French Academy of Sciences. Dr. Berg also serves as the Board liaison to Scientific Advisory Board. Dr. Berg also serves as a director of Gilead Sciences, Inc. and is on the Advisory Board of Schering-Plough BioPharma, a subsidiary of Schering-Plough Corp.
Young, John John A. Young has served as a Director of Affymetrix, Inc. since 1993. Mr. Young retired as President and Chief Executive Officer of Hewlett-Packard Company in October 1992 after a career with the company which began in 1958. He serves as a director of Fluidigm Corporation, Nanosys, Inc. and Perlegen. He is a member of the National Academy of Engineering. He served as co-chairman of President Clinton’s Committee of Advisors on Science and Technology from 1993 to 2000. Mr. Young holds a B.S.E.E. from Oregon State University and an M.B.A. from Stanford University.
Trice, Robert Robert H. Trice has served as a Director of Affymetrix, Inc. since 2006. Dr. Trice has been Senior Vice President for Business Development at Lockheed Martin Corporation since October 1998 and assumed additional duties as Senior Vice President for Strategy and Business Development at Lockheed Martin Corporation effective March 1, 2009.
Wayman, Robert Robert P. Wayman has served as a Director of Affymetrix, Inc. since 2007. Mr. Wayman served as Executive Vice President and Chief Financial Officer of Hewlett-Packard Company from 1984 until his retirement in December of 2006. Mr. Wayman also served as Interim Chief Executive Officer of Hewlett-Packard Company from February 2005 through March 2005 and served on the Board of Directors of Hewlett-Packard Company from February 2005 to March 2007 and from 1993 to 2002. Mr. Wayman has served as a director of Sybase Inc. since 1995.
Guthart, Gary Dr. Gary S. Guthart, Ph.D. has been appointed as a Director of Affymetrix Inc. Dr. Guthart joined Intuitive Surgical in April 1996, was named Chief Operating Officer in 2006, and was promoted to President in 2007. Prior to joining Intuitive Surgical, Dr. Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formally Stanford Research Institute). While at SRI, he also developed technologies for vibration and acoustic control of large-scale systems.

Basic Compensation

Name Fiscal Year Total
Fodor, Stephen 1,585,820
King, Kevin 1,514,390
Batty, John 683,256
Runkel, John 73,528
Diekman, John 255,046
Berg, Paul --
Young, John --
Trice, Robert --
Wayman, Robert --
Guthart, Gary --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Fodor, Stephen 923,603 13,672,174
King, Kevin 0 0
Batty, John 0 0
Runkel, John 0 0
Diekman, John 151,667 3,907,010
Berg, Paul 0 0
Young, John 0 0
Trice, Robert 0 0
Wayman, Robert 0 0
Guthart, Gary 0 0

Insider Trading

Name Shares Traded Price
KING KEVIN M 5,503 $6.91
KING KEVIN M 10,456 $5.95
RUNKEL JOHN F JR 2,682 $8.66
DIEKMAN JOHN D 5,000 $9.90
DIEKMAN JOHN D 5,000 $9.00
KING KEVIN M 50,000 $0.00
FODOR STEPHEN P A 20,000 $0.00
RUNKEL JOHN F JR 8,000 $0.00
BATTY JOHN CARL 8,000 $0.00
DIEKMAN JOHN D 5,000 $9.42
BATTY JOHN CARL 1,162 $5.97
FODOR STEPHEN P A 2,235 $5.97
KING KEVIN M 1,788 $5.97
BATTY JOHN CARL 2,682 $5.78
KING KEVIN M 1,430 $6.07
FODOR STEPHEN P A 1,073 $4.76
BATTY JOHN CARL 8,000 $0.00
FODOR STEPHEN P A 20,000 $0.00
YOUNG JOHN A 500 $3.38
YOUNG JOHN A 3,600 $3.33
YOUNG JOHN A 2,300 $3.36
YOUNG JOHN A 29,972 $3.39
YOUNG JOHN A 1,700 $3.34
YOUNG JOHN A 1,200 $3.37
YOUNG JOHN A 7,428 $3.32
» Full list on Insider Trading
view people for: